Академический Документы
Профессиональный Документы
Культура Документы
EXHIBIT A
This Tolling & Standstill Agreement (the "Agreement") is made and entered into
between (i) the named plaintiffs and putative class of plaintiffs in In re Insulin Pricing Litigation,
No. 3: l 7-cv-00699 (collectively, the "Insulin Plaintiffs"); (ii) MSP Recovery Claims, Series
LLC, MAO-MSO Recovery, LLC, MSPA Claims 1, LLC, and MAO-MSO Recovery II, LLC
(collectively, the "MSP Plaintiffs"); and (iii) Express Scripts Holding Company, Express Scripts
Inc., UnitedHealth Group Incorporated, OptumRx, Inc., CVS Health Corp., Caremark Rx, Inc.
and Caremark Rx, L.L.C. (collectively, the "PBMs," and together with the Insulin Plaintiffs and
the MSP Plaintiffs, the "Parties"), by and through their respective undersigned attorneys.
WHEREAS, between February and April 2017, several related putative class actions
were filed in the United States District Court for the District of New Jersey alleging violations of
federal and state law in connection with the pricing of certain insulin drugs, including In re
Insulin Pricing Litigation, No. 3:17-cv-00699 (filed Feb. 2, 2017), Barnett v. Novo Nordisk, Inc.,
et al., No. 3:17-cv-01580 (filed Mar. 8, 2017), Boss v. CVS Health Corp., et al., No. 3:17-cv-
01823 (filed Mar. 17, 2017) and Christensen v. Novo Nordisk, Inc., eta/., No. 3:17-cv-02678
(filed Apr. 20, 2017) (collectively, the "Insulin Actions"), some of which named the PBMs as
defendants; and
WHEREAS, on September 7, 2017, the MSP Plaintiffs filed a putative class action
captioned MSP Recovery Claims, Series, LLC, et al v. CVS Health Corp., et al., No. 5:17-cv-
00862, ("MSP') in the United States District Court for the Western District of Texas, alleging
violations of federal and state law in connection with the pricing of certain insulin drugs; and
WHEREAS, on September 18, 2017, the Court appointed Steve W. Berman of Hagens
Berman Sobol Shapiro LLP and James E. Cecchi of Carella, Byrne, Cecchi, Olstein, Brody &
1
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 15 of 35 PageID: 1434
Agnello, P.C. (together, "Insulin Counsel") as interim counsel for the Insulin Plaintiffs, which
gives them the authority "to act on behalf of [the] putative class before" the class has been
WHEREAS, on November 17, 2017, the MSP Plaintiffs and the other parties to that
action jointly filed an agreed motion communicating to the MSP court that the "[MSP] Plaintiffs
have voluntarily agreed to litigate the claims made in this case in the District of New Jersey;"
and
WHEREAS, on November 20, 2017, the MSP court entered an order providing that
"[w]ithin 60 days hereof, [MSP] Plaintiffs will either voluntarily dismiss this action without
prejudice or will file a motion to transfer this action to the District of New Jersey"; and
WHEREAS, Insulin Counsel believes it is in the best interest of the Insulin Plaintiffs to
forebear at this time from prosecuting claims against the PB Ms, and on December 26, 2017, filed
a consolidated amended complaint in the Insulin Actions that does not name the PBMs as
defendants; and
WHEREAS, counsel for the MSP Plaintiffs believes it is in the best interest of the MSP
Plaintiffs to forebear at this time from prosecuting claims against the PBMs named as defendants
in MSP and intends to voluntarily dismiss the complaint filed in MSP and to file a complaint in
the District of New Jersey that does not allege claims on behalf of a putative class and does not
WHEREAS, Insulin Counsel and MSP Counsel wish to protect the Insulin Plaintiffs and
MSP Plaintiffs against any and all prejudice that may result from a delay in the prosecution of
claims against the PBMs should it later be decided that the assertion of such claims is in the
2
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 16 of 35 PageID: 1435
WHEREAS, Insulin Counsel, on behalf of the Insulin Plaintiffs, and MSP Counsel, on
behalf of the MSP Plaintiffs, are willing to delay prosecution of claims against the PB Ms, and the
PB Ms are willing to agree that the statute of limitations for the Insulin Plaintiffs' and MSP
Plaintiffs' potential claims may be tolled as to the PBMs in the manner described below; and
agreements herein contained, the Parties hereby covenant and agree as follows:
TERMS OF AGREEMENT
1. The following defined terms used in this Agreement have the meanings set forth
below.
b. "Covered Claim" means any and all manner of claims, debts, demands,
controversies, obligations, losses, costs, interest, penalties, fees, expenses, rights, duties,
action and liabilities, of every nature and description in law or equity (including, but not
limited to, any claims for damages, whether compensatory, special, incidental,
unaccrued, matured or un-matured, known or unknown, arising under federal, state, local,
statutory, common, administrative, or foreign law, or any other law, rule, or regulation,
brought against any of the PB Ms that relates in any way to the pricing of insulin.
c. ''Expiration Date" means the earlier of (a) the date that final judgments
are entered in all of the Insulin Actions, or (b) the date thirty days after Insulin Counsel
3
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 17 of 35 PageID: 1436
gives written notice to the PB Ms that, on the basis of facts or circumstances that Insulin
Counsel learned after executing this Agreement, they are of the view that it is in the
in the Insulin Actions, provided that the date established under subparagraph (b) may not
be earlier than 180 days after the date on which the court has adjudicated all motions to
following plaintiffs named in the consolidated amended complaint filed on December 26,
2017 (ECF No. 82): Henry Appleby, Andre' Arnold, Frank Barnett, Roseanna Barnett,
Andrew Bauer, Aletha Bentele, Julia Blanchette, Mary Bobo, James Bonser, Terry
Brewster, Donald Chaires, Scott Christensen, Julia D' Arrigo, Patricia Dague, Gay
Deputee, Scott Dercks, Mary Ann Devins, Jane Doe, Donald Douthit, F. Donald Fellow,
Mildred Ford, Sarah Gierer, Dianna Gilmore, Gerald Girard, Mark Goldsmith, Michelle
Gwin, Ruth Hart, Diane Halkyard, Sara Hasselbach, David Hernandez, Ritch Hoard,
Michael Horton, Arthur Janz, Emma Jensen, Edward Johnson, Richard Knauss, Angela
Kritselis, Susan Landis, Adam Levett, Jeffrey Liedl, John Loschen, Robert Lowman,
Sean Mac an Airchinnigh, Jeanne MacNitt, Lawrence Mandel, Susan Marsh, Anne
Olinger, Russell Scott Palmer, Juliana Patton, Marilyn Person, Willie Phillips, Patricia
Quint, Donna Ramsey, Robyn Rushing, Marie Saffran, Bertha Sanders, Mark Schloemer,
Howard Schurr, Larissa Shirley, Tremayne Sirmons, Edward Stanford, Michael Starr,
Bret Stewart, Molly Thompson, Jon Ugland, Hector J. Valdes Jr., Hector J. Valdes Sr.,
4
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 18 of 35 PageID: 1437
Andrew Van Houzen, Alethea Weir, Kim and Jim Wallan, and Karyn Wofford, and the
putative class they seek to represent in In re Insulin Pricing Litigation, No. 3:17-cv-
00699.
k. "Timing Defense" means any defense based in whole or in part upon any
statute of limitations, repose period, laches, or any other failure to institute or commence
litigation or other proceedings within a specified period, before a specified date, or before
2. The Insulin Plaintiffs will not assert, commence, prosecute, institute, or instigate
any Covered Claim brought on behalf of a putative class, or in any way participate, other than as
required by law, in the commencement or prosecution of any other action or other proceeding
asserting any Covered Claim brought on behalf of a putative class up to and including the
Expiration Date.
3. The MSP Plaintiffs will not assert, commence, prosecute, institute, or instigate
any Covered Claim, or in any way participate, other than as required by law, in the
commencement or prosecution of any action or other proceeding asserting any Covered Claim up
4. The time that has been running under any applicable Timing Defense in
connection with any Covered Claim is hereby tolled from and including December 26, 2017, up
to and including the Expiration Date. thus, any Covered Claim will be preserved until the
5
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 19 of 35 PageID: 1438
Expiration Date, unless any Timing Defense already has ripened on such claim before December
26, 2017. If any Insulin Plaintiff or any MSP Plaintiff asserts a,Covered Claim after the
Expiration Date, the time for bringing suit under any applicable Timing Defense will be deemed
to have been tolled during the period beginning with and including December 26, 2017 up to and
including the Expiration Date. Notwithstanding the foregoing, for any Covered Claim that an
MSP Plaintiff might have against UnitedHealth Group Incorporated or OptumRx, Inc., the time
for bringing suit under any applicable Timing Defense will not be deemed to have been tolled for
any period. This Agreement will not operate to revive any period of limitations prescribed by
statute or otherwise for the commencement of any action if such period of limitation already has
run as of December 26, 2017. Provided, however, if any Insulin Plaintiff brings a Covered
Claim on behalf of a putative class before the Expiration Date, the PB Ms will have the right to
terminate the Agreement provided that: (1) they give written notice to Insulin Counsel of the
filing of a Covered Claim; and (2) Insulin Counsel is unable to obtain dismissal of that Covered
5. This Agreement will not prevent the Parties from seeking discovery under the
Federal Rules of Civil Procedure ("Rules") from the other Parties to this Agreement-,-Qr from
6. Except as specifically set forth herein with respect to the tolling of Timing
Defenses, this Agreement will not affect the validity of any of the Parties' respective claims or
Party regarding the validity or strength of any claim or defense of any other Party; and nothing
herein will alter the Parties' respective legal or evidentiary burdens with respect to any claim or
defense.
6
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 20 of 35 PageID: 1439
7. This Agreement will affect only the Parties hereto and their counsel, and nothing
herein will affect the claims or potential claims, if any, of other persons, entities or non-parties;
nor will it affect any defenses or affirmative defenses to any claim of other persons, entities or
non-parties.
8. Nothing in this Agreement will bar the Parties from bringing any action or claim
9. The PB Ms will not use this Agreement as a basis to stay any claims against them
in any case other than the Insulin Actions specifically identified in the first whereas clause
above.
10. This Agreement contains the entire agreement between the Parties and constitutes
the complete, final, and exclusive embodiment of their agreement relating to the subject matter
hereof. The terms of this Agreement are contractual and not a mere recital.
11. The signatories to this Agreement represent that they have the requisite authority
to bind and act on behalf of the respective Parties for whom they sign.
12. This Agreement may not be modified except by a written instrument that
explicitly refers to this Agreement, explicitly purports to modify its terms, and is signed by all
Parties hereto.
13. This Agreement will bind and will inure to the benefit of the Parties.
14. This Agreement will be deemed to have been entered into and will be construed
and enforced in accordance with the laws of the State of New Jersey without regard for New
15. This Agreement may be executed in two or more counterparts, each of which will
be deemed an original but all of which together will constitute one and the same instrument.
7
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 21 of 35 PageID: 1440
IN WITNESS WHEREOF, the undersigned have duly authorized and caused this
Agreement to be executed.
By:-----------
Robert A. Fumerton
By:------------- By: - - - - - - - - - - - - - - - - -
Steve W. Berman Brian D. Boone
Thomas M. Sobol William H. Jordan
Hannah W. Brennan Elizabeth Broadway Brown
Jordan E. Edwards
8-
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 22 of 35 PageID: 1441
\.
IN' WITNESS WHEREOF, the undersigned have duly .authorized and caused this
Agreement to be executed.
By:------------ By:
James E. Cecchi Robert A. Fumerton
Lindsey H. Taylor Patrick G. Rideout
By:----------- By:------------
Steve W. Berman Brian D. Boone
Thomas M. Sobol William H. Jordan
Hannah W. Brennan Elizabeth Broadway Brown
Jordan E. Edwards
8
Case 3:17-cv-01823-BRM-LHG Document
--------~--··---·----------·-·-·--·---·-···-··- 67-1 Filed 01/03/19 Page
..······· ··-·-··----'·--'--·-···-'-·--......______ ...........:_................_........___ ...
,
23 of 35 PageID: 1442
Agreement·to be executed.
By: - - - - - - - - - - - - - - - -
Brilill It. Boone
.Berman WilliamH. .Jordan
· omas M. Sobol Elizabeth Broadway Brown
Hannah W. Brennan Jordan E. Edwards
8
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 24 of 35 PageID: 1443
IN WITNESS WHEREOF, the undersigned have duly authorized and caused this
Agreement to be executed.
By:---~-·-~~---
By:----------- Brian D. Boone
Steve W. Berman WiUiam H. Jordan
Thomas M. Sobol Elizabeth Broadway Brown
Hannah W. Brennan Jordan E. Edwards
--------------------------------------·--····--·--·
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 25 of 35 PageID: 1444
By: - - - - - - - - - - - - -
Craig L. Briskin B:12P:lBoeOO:
Daniel Dockery
By:----------- By:-----------
Linda P. Nussbaum Ellen Relkin
Bradley J. Demuth Paul F. Novak
Diana Gjonaj
Gregory Stamatopoulos
By:------------ By:------------
Michael E. Criden Todd A. Seaver
Lindsey C. Grossman Jessica Moy
9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 26 of 35 PageID: 1445
By: - - - - - - - - - - - - - - - By:-----------
Craig L. Briskin Enu Mainigi
Paul Boehm
Daniel Dockery
By: _________........_ _ __
By:-----------
Michael E. Criden Todd A. Seaver
Lindsey C. Grossman Jessica Moy
:9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 27 of 35 PageID: 1446
By:----------- By:------------
Craig L. Briskin Enu Mainigi
Paul Boehm
Daniel Dockery
By: ~--~==-----~
=·····=-·-=-
Linda P. Nussbaum
:IT?Cf/~
Ellen Relkin
Bradley J. Demuth Paul F. Novak
Diana Gjonaj
Gregory Stamatopoulos
By: - - - - - - - - - - - - By: - - - - - - - - - - - -
Michael E. Criden Todd A. Seaver
Lindsey C. Grossman Jessica Moy
9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 28 of 35 PageID: 1447
BERMAN TABACCO
9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 29 of 35 PageID: 1448
By: ____________________
By:-----------
. Craig L. Briskin Enu Mainigi
Paul Boehm
Daniel Dockery
By:----------- By:--------------
Linda P. Nussbaum Ellen Relkin -
Bradley J. Dernuth Paul F. Novak
Diana Gjonaj
Gregory Stamatopoulos
By: - - - - - - - - - - - - - - - - -
Michael E. Criden
Lindsey C. Grossman
9
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 30 of 35 PageID: 1449
By:-----------
Michelle· Rago
By: - - - - - - - - - - - - - - -
Jayne A. Goldstein
Natalie Finkelman Bennett
CA.FFERTY·CLOBES MERIWETHER&
SPRENGEL LLP
By: - - - - - - - - - - - - - - - - By:------------
Lynn Lincoln Sarko Stephen- H. Weil
Derek W. Loeser
Gretchen S. Obrist
Attorneysforlnsu/in Plaintiffs
On behalf of Plaintiffs Halkyard, Sanders,
Wal/an, Ramsey, and Hart
lO
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 31 of 35 PageID: 1450
By:-----------
By:-----------
Michelle Rago
Jayne A. Goldstein
Natalie Finkelman Bennett
By:-----------
Roberta D. Lieben,berg By: ---~----_,.._.,_______---a..,_;:_-=-----
Adam J. Pessin Nyran Ro
Patrick E.
By:------------ By:-----------
Lynn Lincoln Sarka Stephen H. Weil
Derek W. Loeser
Gretchen S. Obrist
Attorneys for Insulin Plaintiffs
On behalfofPlaintiffe Halkyatd, Sanders,
Wallan, Ramsey, and Hart
IO
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 32 of 35 PageID: 1451
By: - - - - - - - - - - - - - - - -
By:-----------
Michelle Rago
Jayne A. Goldstein
Natalie Finkelman Bennett
By:------------
Roberta D. Litrbenberg ·By:------------
Adam J. Pessin Nyran Rose Rasche
Patrick E. Cafferty
By:~1nmt~
Lynn Lincoln Sarko
By:------------
Stephen H. Weil
Derek W. Loeser
Gretchen S. Obrist
10
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 33 of 35 PageID: 1452
By:------------
Michelle Rauo
.e
By:--------------
Jayne A. Goldstein
Natalie Finkelman Rennell
By:~~-~~=~~-............-------
Roberta D. Liebcnbcrg By:-------~---
Adum J. Pc~sin Nyran Rose Rasche
Patrick E. Cafferty
By: - - - - - - - - - ' - - - - - - - , - - -
Lynn Lincoln Sarko
By: ~,i;
St.ire: Weil
1L
Derck W. Loeser
Orcklrnn S. Obri8t
Altonwt·.,ji)r Insulin Plaint!ff.,·
On hcdw(f"~/Plaimil,h.- lla/1'yard. Smulers.
l·Va/lm,; Rmusr.:r. a11d Hatt
JO
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 34 of 35 PageID: 1453
CRITCHLEY, KINUM & DENOIA, LLC SERNA & ASSOClA TES PLLC
By: _ _ _____;;._,;.._;,,;___.,;;._________-'----_
By·----"--------------+--------
Michael Critchley~. Enrique G. Serna
Daniel E. Serna
On behalf ofPlaintiffs Halkyard, Sanders,
Wollan, Ramsey, and Hart Attorneys.for MSP Plaintiffs
11
Case 3:17-cv-01823-BRM-LHG Document 67-1 Filed 01/03/19 Page 35 of 35 PageID: 1454
By:-----------
Michael Critchley
11